Israel's UroGen to start mid-stage bladder cancer trial

RAANANA, Israel (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.

from Reuters: Health News https://ift.tt/2K8Y9b7